A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides

Clinical trial NCT02261493 · COMPLETED

Trial details

NCT number: NCT02261493
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Facial Rhytides Glabellar Rhytides

Start date: 2014-10-27
Primary completion: 2015-06-03
Enrollment: 787

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.